Page last updated: 2024-08-18

pyrroles and Ascites

pyrroles has been researched along with Ascites in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, MC; Chen, CA; Chen, TC; Chen, YL; Cheng, WF; Huang, CT1
Čaržavec, D; Gaćina, P; Kruljac, I; Kust, D; Ostojić, J; Peternac, AŠ; Prpić, M1
Ha, HK; Kim, AY; Kim, HJ; Kim, JS; Lee, JS; Park, SH1
Gao, H; Li, N; Lin, G; Wang, JY; Zhang, SC1
Dahl, E; Gluud, LL; Kimer, N; Krag, A1
Başar, O; Coban, S; Karaahmet, F; Yuksel, O1
Ellis-Grosse, EJ; Guyader, D; Orczyk, GP; Patat, A1
Blei, AT; Blendis, LM; Thuluvath, PJ; Wong, F1
Decaux, G; Djian, J; Gandjini, H; Gerbes, AL; Ginès, P; Gross, P; Gülberg, V1
Hoekman, K; Jorna, AS; Pinedo, HM; Smit, EF; Verheul, HM1
Galambos, JT; Olansky, S; Vogler, WR1

Reviews

1 review(s) available for pyrroles and Ascites

ArticleYear
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:7

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzamides; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Sodium; Spiro Compounds; Tolvaptan; Treatment Outcome

2012

Trials

3 trial(s) available for pyrroles and Ascites

ArticleYear
Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
    Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:5

    Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Double-Blind Method; Drinking; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Pyrroles; Renin; Sodium; Urine; Urodynamics; Vasopressins; Water; Water-Electrolyte Balance

2002
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:1

    Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female; Heart Failure; Hemodynamics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Pyrroles; Renin; Sodium; Thirst; Treatment Outcome; Water-Electrolyte Balance

2003
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
    Gastroenterology, 2003, Volume: 124, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Blood Pressure; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hyponatremia; Kidney; Liver Cirrhosis; Male; Middle Aged; Pyrroles; Sodium; Treatment Outcome; Water

2003

Other Studies

7 other study(ies) available for pyrroles and Ascites

ArticleYear
Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation.
    Cancer letters, 2015, Apr-01, Volume: 359, Issue:1

    Topics: Animals; Antineoplastic Agents; Ascites; Cell Line, Tumor; Coculture Techniques; Dendritic Cells; Female; Humans; Immunity, Cellular; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Interferon-gamma; Interleukins; Lymphocyte Activation; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Staging; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; T-Lymphocytes, Cytotoxic; Time Factors; Transfection; Tumor Necrosis Factor-alpha

2015
Pleural and pericardial effusions combined with ascites in a patient with severe sunitinib-induced hypothyroidism.
    Acta clinica Belgica, 2016, Volume: 71, Issue:3

    Topics: Antineoplastic Agents; Ascites; Carcinoma, Renal Cell; Fatal Outcome; Humans; Hypothyroidism; Indoles; Kidney Neoplasms; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Pyrroles; Sunitinib

2016
Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours.
    European radiology, 2017, Volume: 27, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Disease Progression; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hematoma; Hemoperitoneum; Humans; Imatinib Mesylate; Indoles; Intestine, Small; Male; Middle Aged; Necrosis; Peritonitis; Pyrroles; Rupture, Spontaneous; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Young Adult

2017
Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
    Journal of digestive diseases, 2012, Volume: 13, Issue:1

    Topics: Adult; Aged; Ascites; Biomarkers; Blood Proteins; Drugs, Chinese Herbal; Female; Hepatic Veno-Occlusive Disease; Humans; Liver Failure; Middle Aged; Pyrroles; Pyrrolizidine Alkaloids

2012
Letter: Vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis.
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:11-12

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzamides; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Pyrroles; Spiro Compounds

2012
Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.
    The oncologist, 2000, Volume: 5 Suppl 1

    Topics: Angiogenesis Inhibitors; Antibodies; Ascites; Cell Division; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Humans; Indoles; Lymphokines; Pleural Effusion; Pleural Effusion, Malignant; Protein Isoforms; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Recurrence; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
    The American journal of medicine, 1970, Volume: 49, Issue:3

    Topics: Ascites; Body Temperature; Chemical and Drug Induced Liver Injury; Chloroquine; Chromatography; Feces; Female; Hematologic Diseases; Humans; Iron; Levulinic Acids; Liver Function Tests; Male; Middle Aged; Porphyrias; Porphyrins; Propionates; Pyrroles; Time Factors

1970